MEDPAL AI is trading at £5.40, down -10.03%, after announcing a £5 million placing at 5.0 pence per share.

  • The fundraising issues 100 million new shares and supports working capital.
  • September annualised revenue reached £35 million, up from £28 million in August.
  • Investors appear focused on dilution and funding needs as the broader market rises, making company-specific financing the clearest catalyst.